BridgeMD
New treatment option for Premature Birth
Official title The Effect of the Movement Imitation Therapy in Preterm (MIT-PB) in Motor Behavior's Quality.
ClinicalTrials.gov ID: NCT05319158
What this study is testing
- What it's testing
- This study aims to assess the effect of a parent-administered intervention program based on MIT-PB in preterm with abnormal general movements during the preterm period. We will describe the short and long-term differences between infants exposed to MIT-PB and infants who follow current standard care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 to 32
You may be able to join if
- Preterm infants born before 32w GA and less than 1500g weight.
- Infants who show Abnormal General Movements (CS-PR pattern) at 34-36w postmenstrual age (PMA).
- Families able to understand/speak Catalan, Spanish or English.
- Families willing to participate who have the informed consent
You likely can't join if
- Infants with congenital abnormalities and/or genetic disorders
- Infants with invasive ventilation or Continuous Positive Airway Pressure (CPAP) at 36 weeks PMA.
- Infants with Normal General Movements at 34-36 w PMA.
- Families not willing to participate.
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Barcelona, Spain
- Sabadell, BARCELONA, Spain
- Girona, Girona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 22 weeks to 32 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Barcelona, Spain; Sabadell, BARCELONA, Spain; Girona, Girona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.